The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20250711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Mohamed R Abdelaal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Aus…. Hauptthemen laut MEDLINE: Riboflavin, Histocompatibility Antigens Class I, Minor Histocompatibility Antigens, Antigen Presentation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, National Health and Medical Research Council, Cardiff University.
Abstract (Originalsprache)
MHC class I–related protein (MR1) presents vitamin B–based antigens (Ags) to mucosal-associated invariant T (MAIT) cells. While microbial riboflavin (RF) precursors are well-documented MR1 ligands, it is unclear whether host-generated RF catabolites influence MR1 immunity. Here, we report that RF catabolites, including 10-formylmethylflavin (FMF), lumichrome, lumiflavin, and alloxazine, bind to MR1 with moderate affinity, while RF itself binds weakly. In contrast to the MR1-upregulating microbial RF precursors, RF catabolites reduced the surface level of MR1 by inducing its retention in the endoplasmic reticulum and inhibiting exit. These RF catabolites weakly competed with vitamin B–based Ags for MR1 binding, thereby selectively inhibiting MAIT activation. The crystal structures of MR1 with RF, FMF, lumiflavin, and lumichrome show binding in the A′-pocket of MR1. Here, lumichrome formed a “flavin bond” covalent interaction with MR1-Lys43 differing from the typical Schiff base. Collectively, we identified three-ringed isoalloxazines that bind MR1 and reduce surface levels, suggesting a potential role in dampening MAIT cell immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Infection and Immunity Program and Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
- Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
- Laboratory of Molecular Immunology, Immunology Frontier Research Centre, Osaka University , Suita, Japan.
- Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Australia.
- Institute of Infection and Immunity, Cardiff University School of Medicine , Cardiff, UK.
ORCID-Profile: Mohamed R Abdelaal, Jieru Deng, Mitchell P McInerney, Emi Ito, Anthony W Purcell, Sho Yamasaki, Jose A Villadangos, Hamish E G McWilliam, Nicholas A Gherardin, Jamie Rossjohn, Wael Awad
Förderung
- Australian Research Council
- National Health and Medical Research Council
- Cardiff University
- Monash University, Faculty of Medicine, Nursing and Health Sciences
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Abdelaal, M. R., Deng, J., McInerney, M. P., Ito, E., Purcell, A. W., Yamasaki, S., Villadangos, J. A., McWilliam, H. E. G., Gherardin, N. A., Rossjohn, J., & Awad, W. (2026). The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250711
Vancouver
Abdelaal MR, Deng J, McInerney MP, Ito E, Purcell AW, Yamasaki S, et al. The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20250711
BibTeX
@article{Abdelaal2026,
author = {Abdelaal, Mohamed R and Deng, Jieru and McInerney, Mitchell P and Ito, Emi and Purcell, Anthony W and Yamasaki, Sho and Villadangos, Jose A and McWilliam, Hamish E G and Gherardin, Nicholas A and Rossjohn, Jamie and Awad, Wael},
title = {The antigen-presenting molecule MR1 binds host-generated riboflavin catabolites},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20250711}
}
EUVIMED